David Ryba's Company Details
South San Francisco, CA, US • 250 - 499 Employees
BioTech/Drugs
MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases.
Genetic Heart Disease
Cardiomyopathy
biotechnology
cardiovascular disease
B2B
Biotech
SaaS
Commercial Physical Research
Biotechnology
Biotech Pharmaceuticals